metricas
covid
Buscar en
Hipertensión y Riesgo Vascular
Toda la web
Inicio Hipertensión y Riesgo Vascular Hipertensión arterial en el paciente oncológico con tratamiento con anti-angio...
Journal Information
Vol. 38. Issue 3.
Pages 151-155 (July - September 2021)
Share
Share
Download PDF
More article options
Visits
22
Vol. 38. Issue 3.
Pages 151-155 (July - September 2021)
CASO CLÍNICO
Hipertensión arterial en el paciente oncológico con tratamiento con anti-angiogénicos
Arterial hypertension in cancer patients treated with antiangiogenic agents
Visits
22
R. Roa-Chamorro
Corresponding author
ricardoroa@gmail.com

Autor para correspondencia.
, L. Torres-Quintero, P. González-Bustos
Hospital Universitario Virgen de las Nieves, Granada, España
This item has received
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Tables (1)
Tabla 1. Efectos secundarios cardiovasculares de agentes quimioterápicos con acción anti-angiogénica
Resumen

La mejora de la supervivencia de los pacientes con cáncer ha llevado consigo un incremento en la aparición de enfermedad cardiovascular (ECV). Esto es debido al aumento de la edad de los sujetos y a los efectos secundarios de los agentes antineoplásicos.

La aparición de hipertensión arterial (HTA) en los pacientes tratados con fármacos anti-angiogénicos es un efecto adverso común, que puede obligar a reducir la dosis de quimioterapia o incluso a suspenderla.

Presentamos los casos de tres personas tratadas con distintos anti-angiogénicos, y que desarrollaron HTA secundaria.

Palabras clave:
Cáncer
Hipertensión arterial
Terapia anti-angiogénica
Abstract

Survival of neoplasms has improved significantly in recent years. An increase in the incidence of cardiovascular disease has been observed. This is due to increasing age of patients and the side effects of chemotherapy.

Anti-angiogenic drugs frequently cause hypertension. This may force the reduction or suspension of chemotherapy treatment.

We present the cases of three patients treated with different anti-angiogenic drugs. All three developed secondary arterial hypertension.

Keywords:
Cancer
Arterial hypertension
Anti-angiogenic therapy

Article

These are the options to access the full texts of the publication Hipertensión y Riesgo Vascular
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Hipertensión y Riesgo Vascular

Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

Quizás le interese:
10.1016/j.hipert.2022.05.003
No mostrar más